Poster Archives | サターラ

Poster

Applications of Quantitative Systems Pharmacology Modeling for Vaccine Development

Vaccines play a crucial role in preventing diseases and thereby saving countless lives. To prevent…

Danielle Pillsbury2025年4月24日

Poster

機械的モデリングが二重特異性抗体デザインと標的選択を導き、治療濃度域を最大化

Therapeutic antibodies have shown promise in treating diseases such as cancer, but selectivity remains a…

Danielle Pillsbury2025年3月28日

Poster

Comparison Across Anti-PD-1 Antibodies – Insights From QSP-Based Meta-Analysis

Regulatory-ready systems modeling software to optimize drug developmentDiscover how Certara’s QSP Software can accelerate your…

Danielle Pillsbury2025年3月2日

Poster

バセドウ病眼症の治療を目的とした完全ヒト型抗IL-6抗体TOUR006のフェーズ2b試験における用量選択を支援するためのシミュレーション

Danielle Pillsbury2025年2月7日

Poster

Dose Guidance for a Novel Combination Therapy to Treat Head and Neck Squamous Cell Carcinoma (HNSCC) for Patients with HRAS/PIK3CA Variants Using a Quantitative Systems Pharmacology (QSP) Model

Danielle Pillsbury2025年1月16日

Poster

A Scalable Cloud Platform Accelerates QSP Virtual Patient Generation

Danielle Pillsbury2024年12月13日

Poster

Difference in efficacy between anti-PD-1 and anti-PD-L1 antibodies may be attributable to PD-1:PD-L2 complex inhibition, rather than differences in PD-1:PD-L1 inhibition

Danielle Pillsbury2024年12月13日

Poster

Cumulative drug binding to Cerebral Amyloid Angiopathy (CAA) predicts ARIA-E incidence for anti-Aβ antibodies in Alzheimer’s Disease

Danielle Pillsbury2024年12月13日

Poster

QSP model of neuroinflammation: Effect of TREM2 stimulation on microglial activation and function in the context of Alzheimer’s disease

Danielle Pillsbury2024年12月13日

Poster

Population Pharmacokinetics (PopPK) of Revumenib in Patients with Relapsed/Refractory Acute Leukemias

Danielle Pillsbury2024年12月12日

© 2025 Certara. All Rights Reserved. | 個人情報保護

Powered by Translations.com GlobalLink Web Software